Skip to main content

Animations

MJFF Publications

4491 - 4500 of 8587 Results
Title
Year
  • Year
  • 2015
  • 2020
  • 2020
  • 2020
  • 2018
  • 2024
  • 2016
  • 2020
  • 2020
  • 2023
  • Summary Details
    OPEN
    Title: Improvement of dyskinesias withl-dopa infusion in advanced Parkinson's disease
    Journal Name: Acta Neurologica Scandinavica
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ane.12483
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Differences in the Presentation and Progression of Parkinson's Disease by Sex
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28312
    Citation Count: 79
  • Summary Details
    OPEN
    Title: Brain volumetric deficits in MAPT mutation carriers: a multisite study
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51249
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Kinase Domain Is a Dynamic Hub for Driving LRRK2 Allostery
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2020.538219
    Citation Count: 23
  • Summary Details
    RESTRICTED
    Title: Microlesion effects, suboptimal lead placement and disease progression are critical determinants for DBS tolerance in essential tremor
    Journal Name: Clinical Neurophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.clinph.2018.07.024
    Best OA location URL:
    Citation Count: 4
  • Summary Details
    OPEN
    Title: High‐molecular‐weight oligomer tau (HMWoTau) species are dramatically increased in Braak‐stage dependent manner in the frontal lobe of human brains, demonstrated by a novel oligomer Tau ELISA with a mouse monoclonal antibody (APNmAb005)
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1096/fj.202401704r
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00186
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Assessment of Wearing Off in Parkinson’s disease using objective measurement
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00415-020-10222-w
    Best OA location URL:
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Keep calm and beam on? Unmet needs in radiotherapy and deep brain stimulation
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.01.005
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
    Journal Name: Brain Pathology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/bpa.13196
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.